Robert Menendez actually said...

"The hyper-consolidation, with little to no regulatory oversight, creates inappropriate negotiating leverage that discourages competition and makes it difficult to achieve transparency, affordability, ..."

"Pharmacy benefit managers are key players, or should be, in alleviating patients' financial burden at the pharmacy counter."

"This level of concentration gives these PBMs market power over data, drug coverage, and contracting--80 percent."

"Would patients be better off if PBMs and other supply chain entities were paid flat fees for the services they provide?"